Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Daniel Zingg(The Netherlands Cancer Institute), Jos Jonkers(The Netherlands Cancer Institute)
Cited by 130
Related Papers
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
|Nature Structural & Molecular Biology|2010|1k
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
|Nature Communications|2015|332
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling
|Nature Communications|2022|130